Refractory Pyoderma Gangrenosum in a Patient With Crohn's Disease: Complete Response to Ustekinumab. [electronic resource]
- Journal of Crohn's & colitis May 2019
- 812-813 p. digital
Publication Type: Case Reports; Journal Article
1876-4479
10.1093/ecco-jcc/jjy200 doi
Crohn Disease--complications Dermatologic Agents--therapeutic use Humans Injections, Intravenous Male Middle Aged Pyoderma Gangrenosum--complications Remission Induction Ustekinumab--therapeutic use